MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0017739
Allianz Biosciences Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹87.53 Cr
▲ 30% YoY
Net profit · FY 2022
₹15.57 Cr
Net margin 17.8%
EBITDA · FY 2022
₹26.67 Cr
EBITDA margin 30.5%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹55.04 Lakh
Issued & subscribed
Open charges
₹4.8 Cr
Satisfied ₹10 Lakh
Company age
23 yrs
Est. 2003
Employees · EPFO
123
Provident fund records
About Allianz Biosciences Private Limited
Data last updated:
Allianz Biosciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 January 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2003PTC050203. Its GSTIN is 33AABCH2431G1Z6 (Tamil Nadu). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹55.04 Lakh. It was formerly known as Healkraft Remedies (India) Private Limited. It is led by directors Murugesan Senthil Kumar (Whole-Time Director) and Srinivasan Balamurugan.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2022, the company reported a revenue of ₹87.53 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹15.57 Cr (net margin 17.8%) and EBITDA of ₹26.67 Cr (EBITDA margin 30.5%).
The company has about 123 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Allianz Biosciences. As per MCA filings, the company has open charges of ₹4.8 Cr and satisfied charges of ₹10 Lakh on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 2 cases are pending. The company has 12 deals on record (12 secondary share transfers); the latest was in June 2021.
Allianz Biosciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0017739). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abpl.co.in.
Company details
CIN U24231TN2003PTC050203
Registration Number 050203
Incorporation Date 17 January 2003
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0017739
Recognitions & Rankings of Allianz Biosciences
Contact details
Allianz Biosciences Private Limited's registered office is in Chennai, Tamil Nadu. Its website is abpl.co.in. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressBlock No. 14 R.A. Building III Floor Old No. 19 New No. 72 Marshalls Road, Egmore, Chennai, Tamil Nadu, India – 600008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Allianz Biosciences Private Limited, buy the company report.
Comprehensive company report
Allianz Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Allianz Biosciences operates one associated brand: Allianz Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides probiotic contract manufacturing, packaging, and research services. | abpl.co.in |
Financials of Allianz Biosciences Private Limited
FY 2025 filings availableAllianz Biosciences Private Limited reported revenue of ₹87.53 Cr (up 30% YoY) for FY 2022.
Revenue · FY 2022
₹87.53 Cr ▲ 30%
Net profit · FY 2022
₹15.57 Cr margin 17.8%
EBITDA · FY 2022
₹26.67 Cr margin 30.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 30%
EBITDA CAGR growth
1 year
▲ 58%
Revenue rose 30% in the latest year. EBITDA rose 58% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹87.53 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.5% | ||||
| Net Profit Margin | 17.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Allianz Biosciences Private Limited, buy the company report.
Board of directors of Allianz Biosciences Private Limited
Allianz Biosciences has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasan Balamurugan | Director | 23 Oct 2019 | 7 Years 0 Months | Current |
| Murugesan Senthil Kumar | Whole-Time Director | 08 Jul 2009 | 17 Years 4 Months | Current |
Auditor
Allianz Biosciences Private Limited is audited by M C RANGANATHAN & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M C RANGANATHAN & CO | FY 2022 | 003061S |
Shareholding
The shareholding of Allianz Biosciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Allianz Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.8 Cr
Satisfied charges
₹10 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jul 2011 | 10303858 | Citi Bank N.A. | ₹4.8 Cr | Open | |
| 10 Feb 2020 | 100328743 | State Bank of India | ₹10 Lakh | Satisfied |
To see the full charge records of Allianz Biosciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Allianz Biosciences Private Limited has 12 deals on record (12 secondary share transfers); the latest was in June 2021.
Total deals
12
Secondary share transfers
12
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Secondary share transfer | Undisclosed | Seller: ABPL Family Trust, RSRK Mercntile Private Limited, Jhaver Mercantile Private Limited |
| Feb 2019 | Secondary share transfer | Undisclosed | Seller: Bharat Jhaver HUF, 3 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Bharat Jhaver HUF, 2 individuals Seller: Wood Bird Marketing Private Limited , RSVK Mercantile Private Limited , an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: R K and Sons HUF Seller: RSVK Mercantile Private Limited |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: HKPK Mercantile Private Limited Seller: Wood Bird Marketing Private Limited |
To see the full deal history of Allianz Biosciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Allianz Biosciences Private Limited has 8 court cases on record: 2 filed by Allianz Biosciences, 6 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
2
Filed against the company
6
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 4 | 2 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Court case (REV.APLW) | Filed against the company by Assistant Commissioner of GST and Central Excise Circle III | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by The Commissioner of Income Tax M/S.T.Ravi Kumar, K. Suresh Kumar,R. Hemalatha | Pending |
| District court, Jammu, Jammu and Kashmir | Court case (Criminal Mislaneous) | Filed against the company by an individual | Disposed |
| District court, Jammu, Jammu and Kashmir | Court case (Criminal Mislaneous) | Filed against the company by an individual | Disposed |
| High Court, PONDICHERRY | Interim or miscellaneous application | Filed by the company against Union of India and 2 others | Disposed |
To see the full case history of Allianz Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Allianz Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Allianz Biosciences Private Limited has a workforce of 123 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
123
Active EPFO establishments
1
Employee growth
6.96%
GST
Allianz Biosciences has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCH2431G1Z6 | Tamil Nadu | Active | 01 Jul 2017 |
| 03AABCH2431G1Z9 | Punjab | Active | 01 Jul 2017 |
| 34AABCH2431G1Z4 | Puducherry | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Allianz Biosciences Private Limited, buy the company report.
Recent activity
Allianz Biosciences Private Limited has 10 board changes on record since 2009: 2 appointments and 8 cessations. The latest: Srinivasan Balamurugan ceased to be Additional Director on 26 Dec 2020.
Charges
A charge registered on 10 Feb 2020 via Charge ID 100328743 with State Bank Of India was fully satisfied on 10 Nov 2025.
AGM
Allianz Biosciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Allianz Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Citi Bank N.A. of Rs. 480.00 Lakh registered on 20 Jul 2011 with Charge ID 10303858 was modified on 05 Jun 2023.
Ceased
Srinivasan Balamurugan ceased to be Additional Director.
Ceased
Murugesan Senthil Kumar ceased to be Director.
Ceased
Raghavan Srinivasa Ranganathan ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 100328743 was registered on 10 Feb 2020.
Appointed
Srinivasan Balamurugan was appointed as Director.
Ceased
Venkata Krishna Murty Ponnapalli ceased to be Director.
Ceased
Srinivasan Govindachetty Thommandram ceased to be Manager.
Charges
A charge with Citi Bank N.A. amounted to Rs. 480.00 Lakh with Charge ID 10303858 was registered on 20 Jul 2011.
5 earlier events are in the company report.
Frequently asked questions
Allianz Biosciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 January 2003 (23+ years old) and is registered under CIN U24231TN2003PTC050203.
Allianz Biosciences has 2 current directors:
- Murugesan Senthil Kumar - Whole-Time Director
- Srinivasan Balamurugan - Director
The latest financial statements of Allianz Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Allianz Biosciences is 33AABCH2431G1Z6, registered in Tamil Nadu. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 03AABCH2431G1Z9 (Punjab), 34AABCH2431G1Z4 (Puducherry).
The CIN (Corporate Identification Number) of Allianz Biosciences is U24231TN2003PTC050203. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allianz Biosciences has 8 court cases on record: 2 filed by the company and 6 filed against it. 2 are pending. Most are in the high courts.
Allianz Biosciences was incorporated on 17 January 2003, making it 23+ years old. It is registered with the Registrar of Companies, Chennai.
Allianz Biosciences has 12 deals on record (12 secondary share transfers); the latest was in June 2021.
Srinivasan Balamurugan ceased to be Additional Director on 26 Dec 2020. Murugesan Senthil Kumar ceased to be Director on 01 Nov 2020. Raghavan Srinivasa Ranganathan ceased to be Director on 31 Mar 2020. Allianz Biosciences has 10 board changes on record in total.
Yes, Allianz Biosciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-02-0017739).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages